Related Experiment Video
Updated: May 14, 2026

Toxicological Assays for Testing Effects of an Epigenetic Drug on Development, Fecundity and Survivorship of Malaria Mosquitoes
Published on: January 16, 2015
Anticancer benzimidazole derivatives as inhibitors of epigenetic targets: a review article
Nardin Wagih1, Islam M Abdel-Rahman1, Nawal A El-Koussi1,2
1Pharmaceutical Chemistry Department, Faculty of Pharmacy, Deraya University New Minia 61111 Egypt gamalaburahma@yahoo.com.
Abstract:
Cancer is one of the leading causes of morbidity and mortality worldwide. One of the primary causes of cancer development and progression is epigenetic dysregulation, which is a heritable modification that alters gene expression without changing the DNA sequence. Therefore, targeting these epigenetic changes has emerged as a promising therapeutic strategy. Benzimidazole derivatives have gained attention for their potent epigenetic modulatory effects as they interact with various epigenetic targets, including DNA methyltransferases, histone deacetylases and histone methyltransferases. This review provides a comprehensive overview of benzimidazole derivatives that inhibit different acetylation and methylation reader, writer and eraser epigenetic targets. Herein, we emphasize the therapeutic potential of these compounds in developing targeted, less toxic cancer therapies. Presently, some promising benzimidazole derivatives have entered clinical trials and shown great advancements in the fields of hematological and solid malignancy therapies. Accordingly, we highlight the recent advancements in benzimidazole research as epigenetic agents that could pave the way for designing new multi-target drugs to overcome resistance and improve clinical outcomes for cancer patients. This review can help researchers in designing new anticancer benzimidazole derivatives with better properties.
Insights
Benzimidazole derivatives show promise as targeted cancer therapies by modulating epigenetic changes. These compounds offer a potential strategy for developing less toxic treatments and improving patient outcomes.
Area of Science:
- Oncology
- Epigenetics
- Medicinal Chemistry
Background:
- Cancer remains a major global health challenge, with epigenetic dysregulation significantly contributing to its development and progression.
- Epigenetic modifications, which alter gene expression without changing DNA sequence, are increasingly recognized as critical therapeutic targets.
- Targeting epigenetic mechanisms offers a promising avenue for developing novel, less toxic cancer treatments.
Purpose of the Study:
- To provide a comprehensive review of benzimidazole derivatives as epigenetic modulators in cancer therapy.
- To highlight the therapeutic potential of benzimidazole derivatives targeting DNA methyltransferases, histone deacetylases, and histone methyltransferases.
- To emphasize recent advancements and future directions for benzimidazole-based epigenetic drugs in oncology.
Main Methods:
- Literature review focusing on benzimidazole derivatives and their interaction with epigenetic targets (readers, writers, erasers).
- Analysis of studies investigating the efficacy of benzimidazole derivatives in preclinical and clinical cancer models.
- Synthesis of information on the mechanisms of action and therapeutic potential of these compounds.
Main Results:
- Benzimidazole derivatives exhibit potent inhibition of key epigenetic targets involved in cancer.
- Several promising benzimidazole derivatives are advancing through clinical trials for hematological and solid malignancies.
- These compounds demonstrate potential for developing targeted, less toxic cancer therapies.
Conclusions:
- Benzimidazole derivatives represent a valuable class of epigenetic agents for cancer treatment.
- Further research into benzimidazole derivatives could lead to the design of multi-target drugs to overcome resistance and improve clinical outcomes.
- This review serves as a resource for researchers developing novel anticancer benzimidazole derivatives with enhanced properties.
Related Concept Videos
Epigenetic Regulation
Epigenetic Regulation
Drugs that Stabilize Microtubules
Inhibition of Cdk Activity
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Epigenetic Regulation
X-chromosome...

